PharmaCyte Biotech, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 2/22/2017
Contact Info
  • 23046 Avenida de la Carlota
  • Suite 600
  • Laguna Hills, CA 92653

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jan 31, 2017 10-Q
CIK 0001157075
Fiscal Year End 4/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: NV, USA
Year of Inc. 1996
Employees 10 a/o Feb 06, 2017
Company Officers/Contacts
Kenneth L. Waggoner CEO, President, General Counsel
Gerald W. Crabtree, Ph.D. COO
Company Directors
Kenneth L. Waggoner Chairman
Thomas Liquard Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Gerald W. Crabtree, Ph.D. Audit Committee Member, Compensation Committee Member
Service Providers
Accounting/Auditing Firm
Armanino LLP
12657 Alcosta Blvd
Suite 500
San Ramon, CA, 94583
United States
Securities Counsel
Pepper Hamilton LLP
New York Times Building
620 Eighth Avenue/37th Floor
New York, NY, 10018-1405
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=Nuvilex, Inc. until 1-2015
  •, Inc. until 3-2009
PMCB Security Details
Share Structure
Market Value1 $48,141,974 a/o Jun 22, 2017
Authorized Shares 1,490,000,000 a/o Feb 06, 2017
Outstanding Shares 875,308,610 a/o Mar 13, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 842,537,909 a/o Feb 06, 2017
Par Value 0.0001
Shareholders of Record 1,317 a/o Feb 06, 2017
Short Selling Data
Short Interest 564,338 (153.18%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security